Discover 1,068 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,068
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Dothan AL, Atlanta GA, Decatur GA, Lawrenceville GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Birmingham AL, Atlanta GA, Pensacola FL,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & ResponsiveNew
Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients
for
Gingivitis, DMFT Index, Dental Plaque Index,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 14 - 19
Code: NCT07164989
Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Anniston AL, Cullman AL, Atlanta GA, Stockbridge GA,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
Early Intervention to Promote Cardiovascular Health of Mothers and Children
for
Cardiovascular Health
Location: Birmingham AL, Winston-Salem NC, St Louis MO,
Sponsor: JHSPH Center for Clinical Trials
Sex: Female
Age: 18+
Code: NCT06272045
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer